Japan Artificial Organs Bionic Implants Market Insights Forecasts to 2032

• The Market Size is Growing at a CAGR of 5.9% from 2022 to 2032.
• The Japan Artificial Organs Bionic Implants Market Size is Expected to Hold a Significant Share by 2032.

The Japan Artificial Organs Bionic Implants Market Size is Expected to hold a significant share by 2032, at a CAGR of 5.9% during the forecast period 2022 to 2032. 

Market Overview

Artificial organs and bionic implants are medical devices that can be worn on the outside or implanted. Artificial organs are implanted in the body to replace natural organs if a natural organ fails or if any organ is damaged by an external factor such as an accident. The most common causes of organ failure are excessive blood loss, drug abuse, severe trauma, and other acute diseases. In addition, poor dietary habits, smoking, excessive alcohol consumption, and a lack of exercise are major causes of organ failure. Implantable devices with mechanical and electrical components are known as bionic implants. They are divided into two categories: biology and electronics. They are also advanced forms of robotic technology. Biomaterials, are engineered substances that interact with biological systems and are used in the construction of artificial organs and bionic implants, are used in the construction of artificial organs and bionic implants.

Report Coverage

This research report categorizes the market for the Japan artificial organs bionic implants market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan artificial organ bionic implants market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan artificial organs bionic implants market.

Driving Factors

In the coming years, several vehicle accidents, injuries, and disabilities are expected to drive market growth. During the forecast period, the rising number of patients waiting for organ transplants will be a major driver of market growth. Furthermore, increased technological advancements and government support are expected to create enormous opportunities for market participants. The availability of advanced artificial support systems, as well as technological advancements in healthcare facilities, are expected to drive up demand for artificial organs and bionics implants.

Restraining Factors

In addition to the high cost of the devices, they are prohibitively expensive for middle-class people and individuals in developing economies. This, to some extent, limits market growth. The reimbursement policies are complicated and uncertain, making them even more difficult to afford for ordinary people.

Market Segment

• In 2022, the orthopedic bionics segment accounted for the significant revenue share over the forecast period.

Based on the types, the Japan artificial organs bionic implants market is segmented into bionics and artificial organs. The bionics segment is further divided into cardiac bionics, orthopedic bionics, vision bionics, and others. The artificial organs segment is further segmented into cochlear implants, artificial lungs, artificial kidneys, artificial hearts, and others. Among these, the orthopedic bionics segment has the significant revenue share over the forecast period. Due to the increasing cases of road casualties, physical disability, trauma, the presence of diseases that may lead to limb impairment, and technological advancements. The risk of bone damage may increase as a result of the high number of road accidents, leading to an increase in orthopedic bionics. Similarly, rising disability rates are driving up demand for orthopedic bionics and propelling the segment forward. A significant portion of this total disability may be orthopedic, increasing demand for orthopedic bionics and contributing to the growth of this segment.

• In 2022, the externally worn segment accounted for the largest revenue share over the forecast period.

Based on methods of fixation, the Japan artificial organs bionic implants market is segmented into externally worn and implantable. Among these, the externally worn segment accounted for the largest revenue share over the forecast period. The introduction of new improved gadgets that are coupled with technological benefits as technology advances, and the most important aspect of such implants is that they function as if they were normal organs, with no interruptions. Artificial organs and bionic implants are medical devices used to replace or improve the functionality of damaged or non-functioning organs in the human body.

• In 2022, the hospitals segment accounted for the largest revenue share over the forecast period.

Based on application, the Japan artificial organs bionic implants market is segmented into clinical research institutions, hospitals, and others. Among these, the hospitals segment accounted for the largest revenue share over the forecast period. The presence of modern healthcare infrastructure and trained physicians improves hospital procedural adoption rates. The availability of cutting-edge technology in hospitals is propelling the market segment forward.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan artificial organs bionic implants market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abiomed, Inc.
• Asahi Kasei Medical Co. Ltd.
• Baxter International, Inc.
• Berlin Heart GmbH
• Boston Scientific Corporation
• Cochlear Limited
• Cyberonics Inc.
• Carl Bennet AB (Getinge AB)
• Medtronic PLC
• Ossur hf.
• Heartware International, Inc
• Zimmer Biomet Holdings, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In March 2022, The Kyushu University Inoue Harushige Prize Award was given to scientists from Japan's Department of Biomaterials for developing the chemical composition for artificial bone composition (carbonate apatite).

• In February 2022, using cultured embryonic stem cells, a team from Kumamoto University in Japan created 3-dimensional kidney tissue from scratch in their lab.

Market Segment

This study forecasts revenue at regional, and country levels from 2021 to 2032. Spherical Insights has segmented the Japan Artificial Organs Bionic Implants Market based on the below-mentioned segments:

Japan Artificial Organs Bionic Implants Market, By Types

Bionics

• Cardiac Bionics
• Orthopedic Bionics
• Vision Bionics
• Others

Artificial Organs

• Cochlear Implants
• Artificial Lungs
• Artificial Kidneys
• Artificial Hearts
• Others

Japan Artificial Organs Bionic Implants Market, By Methods of Fixation

• Externally Worn
• Implantable

Japan Artificial Organs Bionic Implants Market, By Technology

• Electronic
• Mechanical

Japan Artificial Organs Bionic Implants Market, By Application

• Clinical Research Institutions
• Hospitals
• Others